A Randomized, Placebo-controlled, Double-blind, Multicenter Phase II Study of Atezolizumab With or Without Entinostat in Patients with Advanced Triple Negative Breast Cancer, with a Phase Ib Lead in Phase
ClinicalTrials.Gov
View All Studies